Pilot Study: Effects of Parenteral Glutamine Dipeptide Supplementation on Neutrophil Functions and Prevention of Chemotherapy-Induced Side-Effects in Acute Myeloid Leukaemia Patients
Authors:
- 1 December 2008
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 36 (6) , 1383-1391
Abstract
The effect of parenteral glutamine dipeptide (Gln) supplementation on neutrophil phagocytosis, superoxide anion generation (SAG), prevention of chemotherapy-induced side-effects and cost-effectiveness was examined in a pilot study of acute myeloid leukaemia (AML) patients receiving chemotherapy. Sixteen AML patients were randomized to receive intravenous supplementation with Gln (30 g/day) or an equivalent quantity (25 g/day) of a standard amino acid mixture (control) on days 1 − 5 of chemotherapy. Complete blood count was evaluated twice a week until hospital discharge, and neutrophil phagocytosis and SAG were measured when absolute neutrophil count reached > 500 /μl. Patients were observed for development of infection, mucositis and diarrhoea. In Gln-treated patients, the percentage of neutrophil phagocytosis and the SAG levels were significantly higher than in control patients (20.5 ± 6.0% and 18.9 ± 2.9 nmol/106 neutrophils per 10 min, respectively). The Gln-treated patients lost significantly less weight, tended to have shorter in-patient duration and had less severe oral mucositis than controls. This pilot study provides preliminary indication that parenteral Gln supplementation enhances neutrophil phagocytic function, maintains nutritional status and is cost effective. Parenteral Gln may also prevent oral mucositis, although further studies involving more patients need to be undertaken to confirm this and the other results.Keywords
This publication has 19 references indexed in Scilit:
- Prevention of chemotherapy and radiation toxicity with glutamineCancer Treatment Reviews, 2003
- Glutamine and glutamate—their central role in cell metabolism and functionCell Biochemistry and Function, 2002
- Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemiaAnnals of Hematology, 1999
- Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapyCancer, 1998
- Impaired granulocytic function in patients with acute leukaemia: only partial normalisation after successful remission-inducing treatmentJournal of Cancer Research and Clinical Oncology, 1998
- Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophilsBritish Journal of Pharmacology, 1997
- Glutamine supplementation in cancer patients receiving chemotherapy: A double-blind randomized studyNutrition, 1997
- 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementationBritish Journal of Cancer, 1994
- Effect of Glutamine on Phagocytosis and Bacterial Killing by Normal and Pediatric Burn Patient NeutrophilsJournal of Parenteral and Enteral Nutrition, 1994
- Clinical and Metabolic Efficacy of Glutamine-supplemented Parenteral Nutrition after Bone Marrow TransplantationAnnals of Internal Medicine, 1992